Literature DB >> 12034749

Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate.

Jeffrey C Mai1, Hongmei Shen, Simon C Watkins, Tao Cheng, Paul D Robbins.   

Abstract

Protein transduction domains (PTDs), both naturally occurring and synthetic, have been increasingly utilized to deliver biologically active agents to a variety of cell types in vitro and in vivo. We report that in addition to previously characterized arginine-rich PTDs, including TAT, lysine homopolymers were able to mediate transduction of a wide variety of cell types, as measured by flow cytometric and enzymatic assays. The efficiency of PTD-mediated transduction was influenced by the cell type tested, although polylysine homopolymers demonstrate levels of internalization that consistently exceeded those of TAT and arginine homopolymers. Transduction of arginine/lysine-rich PTDs occurred at 4 degrees C and following depletion of cellular ATP pools, albeit generally at reduced levels. Although transduction was reduced in Chinese hamster ovary mutant lines deficient in either heparan sulfate or glycosaminoglycan synthesis, uptake was restored to wild-type levels by incubating target cells with dextran sulfate. The enhancement of transduction by dextran sulfate suggests that electrostatic interactions play an important first step in the process by which PTDs and their cargo traverse the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034749     DOI: 10.1074/jbc.M204202200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.

Authors:  J P M Langedijk; T Olijhoek; D Schut; R Autar; R H Meloen
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

Review 2.  Cell penetrating peptides in drug delivery.

Authors:  Eric L Snyder; Steven F Dowdy
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 3.  Protein transduction technology.

Authors:  Masayuki Matsushita; Hideki Matsui
Journal:  J Mol Med (Berl)       Date:  2005-02-10       Impact factor: 4.599

4.  On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.

Authors:  Miguel Mano; Cristina Teodósio; Artur Paiva; Sérgio Simões; Maria C Pedroso de Lima
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 5.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

6.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

7.  Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu
Journal:  J Vis Exp       Date:  2015-03-25       Impact factor: 1.355

Review 8.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

9.  Protein delivery using Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu; Kimberly E Anderson; Shannon J Sirk; Carlos F Barbas
Journal:  ACS Chem Biol       Date:  2014-06-19       Impact factor: 5.100

10.  Cell-free production of transducible transcription factors for nuclear reprogramming.

Authors:  William C Yang; Kedar G Patel; Jieun Lee; Yohannes T Ghebremariam; H Edward Wong; John P Cooke; James R Swartz
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.